Dare Bioscience, Inc. — Director's Dealing 2018

Jul 11, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Dare Bioscience, Inc. (DARE)
CIK: 0001401914
Period of Report: 2018-07-10

Reporting Person: Steele Robin Joan (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-07-10	Stock Option (right to buy)	$1.35	A	45000	Acquired	2028-07-10	Common Stock (45000)	Direct

Footnotes

F1: This option vests as to 1/3rd of the shares subject to this option on each of July 10, 2019, 2020 and 2021, subject to the reporting person's continued service to the issuer, and will become exercisable in full upon a change of control of the issuer.